Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Toxicol Rep ; 6: 904-913, 2019.
Article in English | MEDLINE | ID: mdl-31508319

ABSTRACT

Focusing on licorice, a highly used raw material in health foods, quantitative analysis of functional/medicinal components and a safety and functional evaluation was carried out for herbal medicines, health food ingredients, and so-called health foods. A functional component, glabridin, was detected in herbal medicines from Glycyrrhiza glabra and G. inflata, health food ingredients, and in commercially available health foods that contain licorice. Likewise, glycyrrhizin, a medicinal component, was detected in these sources, except in licorice oil extract. Estrogen activity in vitro was detected in some of the herbal medicines, health food ingredients, and in health foods containing licorice. In the in vivo study, liver weight in ovariectomized (OVX) mice treated with licorice oil extract was significantly higher than that in OVX and sham mice in a dose dependent manner. These results suggest that excessive intake of licorice oil extract from health foods should be avoided, even though these ingredients might be beneficial for medical use in order to maintain bone health in postmenopausal women. Measurement of hepatic cytochrome P-450 (CYP) activity, reproductive organ weight, and fat and bone mass in OVX mice was considered useful for evaluating the safety and efficacy of estrogenic health food ingredients derived from herbal medicines.

2.
J Nutr Sci Vitaminol (Tokyo) ; 61 Suppl: S142-4, 2015.
Article in English | MEDLINE | ID: mdl-26598831

ABSTRACT

New Zealand is a rich source of food components that may have bioactivity on bone. Docosahexaenoic acid (DHA) from fish oil has been shown to maintain bone in ovariectomised (OVX) rats. Kiwifruit, a source of fibre and carotenoids, may also affect bone via a prebiotic as well as direct cell-based mechanisms. We aimed to 1) ascertain the effects of DHA on two cell models, including interactions with soy isoflavones; 2) and investigate the specific effects of carotenoids from kiwifruit as well as whole kiwifruit in cell-based and rodent models as well as in a human study. RAW 264.7 mouse monocytes or mouse bone marrow was used to generate osteoclasts (OC). Cells were exposed to the agents between 5 and 21 d and formation and activity of OC measured, including molecular markers. DHA inhibited OC formation in both cell models, including expression of cathepsin K, NFATc1 as well as actin ring formation. Combination with isoflavones enhanced these effects. In OVX rats and mice fed with kiwifruit for 8 wk, green kiwifruit reduced the rate of bone loss after OVX, and in mice it reduced C-telopeptide of Type 1 collagen (CTX) levels and RANKL expression while in menopausal women, green kiwifruit affected blood lipids and bone markers positively.


Subject(s)
Actinidia , Bone and Bones/drug effects , Docosahexaenoic Acids/therapeutic use , Functional Food , Glycine max/chemistry , Osteoporosis/prevention & control , Phytoestrogens/therapeutic use , Animals , Bone Density/drug effects , Bone Resorption/metabolism , Bone Resorption/prevention & control , Bone and Bones/metabolism , Carotenoids/pharmacology , Carotenoids/therapeutic use , Diet , Docosahexaenoic Acids/pharmacology , Female , Fruit , Humans , Isoflavones/pharmacology , Isoflavones/therapeutic use , Mice , New Zealand , Osteoporosis/metabolism , Phytoestrogens/pharmacology , Phytotherapy , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , RAW 264.7 Cells , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...